Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
376-390 of 2993 results
FDA grants EUA status for Hologic’s Aptima Zika Virus assay
By MDBR Staff Writer
Hologic has secured emergency use authorization (EUA) status from the US Food and Drug Administration (FDA) for its new Aptima Zika Virus assay.
Diagnostics > In Vitro Diagnostics > News
Great Basin Scientific introduces enhanced molecular diagnostic analyzer
By MDBR Staff Writer
Great Basin Scientific has unveiled its enhanced molecular diagnostic analyzer, which the company claims will decrease test time and increase throughput for labs.
Diagnostics > In Vitro Diagnostics > News
Alere q HIV-1/2 Detect point-of-care molecular HIV assay receives WHO prequalification
By MDBR Staff Writer
Alere, a global leader in rapid diagnostics, today announced that its Alere™ q HIV-1/2 Detect assay has been awarded World Health Organization (WHO) prequalification, making it available for public sector procurement.
Diagnostics > In Vitro Diagnostics > News
Protagen’s Multilisa BICD2 test wins CE Mark approval to diagnose systemic sclerosis
By MDBR Staff Writer
Germany-based Protagen has received CE mark approval for its Multilisa BICD2 test to diagnose systemic sclerosis (SSc).
Diagnostics > In Vitro Diagnostics > News
Avacta and Mologic partner to develop novel diagnostic tests
By MDBR Staff Writer
Avacta Group has partnered with Mologic to develop diagnostic tests against several targets of clinical interest for point of care (POC) testing.
Diagnostics > In Vitro Diagnostics > News
Great Basin begins clinical trial for stool bacterial pathogens panel
By MDBR Staff Writer
Great Basin Scientific, a molecular diagnostics company, announced today that it has initiated a clinical trial for its Stool Bacterial Pathogens Panel, a multi-plex molecular assay detecting common bacterial agents, including foodborne pathogens, present in individuals suspected of acute gastroenteritis.
Diagnostics > In Vitro Diagnostics > News
GenMark gets CE mark approval for ePlex molecular diagnostics system
By MDBR Staff Writer
GenMark Diagnostics has secured CE mark approval for its ePlex instrument system and ePlex respiratory pathogen (RP) panel.
Diagnostics > In Vitro Diagnostics > News
ArcherDX partners with Illumina to bring Fusion oncology assays to global markets
By MDBR Staff Writer
ArcherDX announced a co-marketing and distribution agreement with Illumina (ILMN).
Diagnostics > In Vitro Diagnostics > News
Abaxis Global Diagnostics and AAHA develop preventive care testing initiative
By MDBR Staff Writer
Abaxis, a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced a partnership with the American Animal Hospital Association (AAHA) to develop a wellness testing initiative that is focused on improving compliance for blood diagnostic testing.
Diagnostics > In Vitro Diagnostics > News
LabCorp launches RealStar Zika virus test in US
By MDBR Staff Writer
Laboratory Corporation of America Holdings (LabCorp) has launched the RealStar Zika virus test in the US.
Diagnostics > In Vitro Diagnostics > News
NantHealth announces commercial availability of GPS Cancer molecular test
By MDBR Staff Writer
NantHealth announced the commercial availability of Genomic Proteomic Spectrometry Cancer, or GPS CancerT, a unique, comprehensive molecular test and decision support solution that measures the proteins present in the patient's tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor & normal samples.
Diagnostics > In Vitro Diagnostics > News
Definiens and MolecularMD partner to combine IHC assays with advanced digital pathology and data mining
By MDBR Staff Writer
Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced a partnership agreement with MolecularMD to combine MolecularMD’s expertise in specialty diagnostic assays with Definiens’ quantitative tissue read-outs.
Diagnostics > In Vitro Diagnostics > News
AstraZeneca, Foundation Medicine partner to develop companion diagnostic assay for Lynparza
By MDBR Staff Writer
AstraZeneca ans Foundation Medicine have collaborated to develop a new companion diagnostic assay for Lynparza (olaparib) oral poly ADP-ribose polymerase (PARP) inhibitor.
Diagnostics > In Vitro Diagnostics > News
Avant acquires Amarantus Diagnostics
By MDBR Staff Writer
Avant Diagnostics has completed the acquisition of Amarantus BioScience's subsidiary Amarantus Diagnostics.
Diagnostics > In Vitro Diagnostics > News
Admera Health launches Archer FusionPlex assay services
By MDBR Staff Writer
ArcherDX, the leader in NGS-based gene fusion detection, announced the addition of renowned molecular diagnostics company Admera Health as a Certified Service Provider (CSP) of Archer® FusionPlex assays.
Diagnostics > In Vitro Diagnostics > News
376-390 of 2993 results